117 related articles for article (PubMed ID: 1623213)
1. Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer.
Kusumoto H; Maehara Y; Yoshida M; Takahashi I; Anai H; Sugimachi K
Anticancer Drugs; 1992 Feb; 3(1):33-8. PubMed ID: 1623213
[TBL] [Abstract][Full Text] [Related]
2. Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma.
Maehara Y; Anai H; Kusumoto H; Sugimachi K
Eur J Surg Oncol; 1987 Jun; 13(3):203-6. PubMed ID: 3036603
[TBL] [Abstract][Full Text] [Related]
3. Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil.
Maehara Y; Anai H; Kusumoto H; Kusumoto T; Sugimachi K
Dis Colon Rectum; 1988 Jan; 31(1):62-7. PubMed ID: 3130239
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of SDI test for predicting effect of postoperative chemotherapy for patients with gastric cancer.
Baba H; Takeuchi H; Inutsuka S; Yamamoto M; Endo K; Ohno S; Maehara Y; Sugimachi K
Semin Surg Oncol; 1994; 10(2):140-4. PubMed ID: 8052784
[TBL] [Abstract][Full Text] [Related]
5. Tumor tissue is more sensitive to mitomycin C, carboquone, and aclacinomycin A than is adjacent normal tissue in vitro.
Maehara Y; Kusumoto H; Kusumoto T; Anai H; Sugimachi K
J Surg Oncol; 1989 Jan; 40(1):4-7. PubMed ID: 2909804
[TBL] [Abstract][Full Text] [Related]
6. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
Ohyama S; Yonemura Y; Kinoshita K; Ninomiya I; Tugawa K; Kimura H; Miyazaki I; Tanaka M; Endo Y; Sasaki T
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
[TBL] [Abstract][Full Text] [Related]
7. Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin.
Okuyama T; Maehara Y; Endo K; Baba H; Adachi Y; Kuwano M; Sugimachi K
Cancer; 1994 Aug; 74(4):1230-6. PubMed ID: 8055443
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitivity differences between primary and metastatic lesions of clinical gastric cancer.
Kusumoto H; Maehara Y; Kusumoto T; Anai H; Akazawa K; Sugimachi K
Eur J Surg Oncol; 1988 Dec; 14(6):685-9. PubMed ID: 3192005
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to six antitumor drugs differs between primary and metastatic liver cancers.
Kanematsu T; Maehara Y; Kusumoto T; Sugimachi K
Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1511-3. PubMed ID: 2846313
[TBL] [Abstract][Full Text] [Related]
10. Resistance to anticancer drugs of well differentiated gastric adenocarcinoma with venous invasion.
Sakaguchi Y; Anai H; Kohnoe S; Emi Y; Kusumoto T; Maehara Y; Sugimachi K
Eur J Surg Oncol; 1992 Apr; 18(2):142-5. PubMed ID: 1582507
[TBL] [Abstract][Full Text] [Related]
11. [Flow cytometric DNA analysis and chemosensitivity in squamous cell carcinoma of the head and neck].
Miyagi M; Soda T; Nakashima T
Nihon Jibiinkoka Gakkai Kaiho; 1994 Dec; 97(12):2247-58. PubMed ID: 7861297
[TBL] [Abstract][Full Text] [Related]
12. Lung adenocarcinoma is more sensitive than gastric adenocarcinoma to anticancer drugs in vitro.
Kohnoe S; Moriguchi S; Emi Y; Sakaguchi Y; Maehara Y; Ishida T; Mitsudomi T; Sugimachi K
Eur J Surg Oncol; 1991 Feb; 17(1):47-50. PubMed ID: 1995357
[TBL] [Abstract][Full Text] [Related]
13. Expression of P-glycoprotein influences resistance against anthracyclines in clinical gastric carcinomas.
Orita H; Maehara Y; Anai H; Baba H; Kusumoto H; Korenaga D; Sugimachi K
Semin Surg Oncol; 1994; 10(2):135-9. PubMed ID: 7914378
[TBL] [Abstract][Full Text] [Related]
14. Antitumor chemosensitivity differs between clinical sarcoma and adenocarcinoma tissues.
Takeuchi H; Baba H; Inutsuka S; Takahashi I; Kusumoto H; Maehara Y; Sugimachi K
Anticancer Res; 1994; 14(1A):169-71. PubMed ID: 8166444
[TBL] [Abstract][Full Text] [Related]
15. Chemosensitivity correlation between the primary tumors and simultaneous metastatic lymph nodes of patients evaluated by DNA synthesis inhibition assay.
Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Cancer; 1990 Mar; 65(6):1273-8. PubMed ID: 2106383
[TBL] [Abstract][Full Text] [Related]
16. [The sensitivity of 1,000 human tumors to antitumor drugs using the succinate dehydrogenase inhibition (SDI) test].
Miyamoto K; Fukuchi K
Rinsho Byori; 1990 Nov; 38(11):1273-8. PubMed ID: 2273570
[TBL] [Abstract][Full Text] [Related]
17. [Multi-institutional feasibility study of SDI test for its application to the adjuvant chemotherapy of gastric cancer].
Yamauchi M; Kondo T
Gan To Kagaku Ryoho; 1993 Mar; 20(4):432-9. PubMed ID: 8452380
[TBL] [Abstract][Full Text] [Related]
18. [Study on the chemosensitivity test of human gastric cancer using the MTT assay].
Chen Z; Hu J; Chen J; Yan L; Mao Y; Zou L
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):134-5. PubMed ID: 12733380
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of chemosensitivity testing with highly purified tumor cells in 435 patients with gastric carcinoma using an MTT assay.
Noguchi K; Iwahashi M; Tani M; Nakamura M; Nakamori M; Nakatani Y; Ueda K; Ishida K; Naka T; Ojima T; Hotta T; Mizobata S; Yamaue H
Anticancer Res; 2005; 25(2A):931-7. PubMed ID: 15868930
[TBL] [Abstract][Full Text] [Related]
20. [Drug sensitivity test and drug-resistance gene assessment for chemotherapy planning for tumors derived from high-passage mouse gastric cancer cells: therapeutic effect observation in mice].
Sun T; Zhang JR; Jia HS
Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):712-4. PubMed ID: 17545096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
